Components in tobacco smoke and electronic cigarette form adducts with DNA.

Air 2, LLC

Components in tobacco smoke and electronic cigarette (e-cigarette) aerosol form adducts with DNA, which can cause DNA mutations and affect repair of DNA damage. 

DNA adducts are significant biomarkers of tobacco exposure
Numerous studies have shown a strong association between inhaled smoke and lung cancer. The presence of DNA adducts can indicate chemical components of smoke. Therefore, DNA adducts are significant biomarkers of tobacco exposure that might predict lung disease status and serve as precursors to lung cancer, since they trigger DNA mutations and impair biological processes such as DNA replication and transcription.


In 2019, the United States experienced an outbreak of lung injuries
In recent years, e-cigarettes have been popular among young people because of their unique flavor and they are considered a substitute for conventional cigarettes. However, e-cigarettes are not harmless. In 2019, the United States experienced an outbreak of lung injuries associated with the use of e-cigarettes and e-cigarette products, thus resulting in 2800 hospitalizations, and highlighting the dangers of e-cigarettes and products.


Chemical carcinogens in conventional cigarettes and e-cigarettes

Conventional cigarette smoke and e-cigarette aerosol contain different types and concentrations of chemical carcinogens. Many chemical carcinogens in conventional cigarettes and e-cigarettes are reactive and challenging to measure directly.

Biological Consequence
The formation of DNA adducts is a crucial initial event in the induction of mutations and triggering of cancer development through chemical carcinogens, thus linking chemical carcinogens to cancer occurrence at the molecular level. The biological effects of DNA adducts include impeding DNA replication, inducing mutations that can lead to cancer, and being closely associated with aging


VIEW ENTIRE ARTICLE


By Air 2, LLC September 8, 2025
Exclusive: US FDA to fast-track nicotine pouch reviews amid White House pressure.
By Air 2, LLC August 19, 2025
How BAT’s tobacco-free oral nicotine strategy is reshaping the public health conversation in the Middle East.
By Air2, LLC August 6, 2025
Federal Judge Rules FDA Tobacco Penalties Unconstitutional Without Jury Trial.
By Air 2, LLC July 22, 2025
A cross between a nicotine pouch and an energy drink: What to know about caffeine pouches.
By Air 2, LLC July 8, 2025
The race is on for success in harm reduction: encouraging smokers to switch completely to reduced risk alternatives. Evidence of this rapidly evolving trend can be seen from all lanes — consumers, manufacturers, retailers, the government and even public health.
BAT AIR2 VAPOR
By Air 2, LLC June 23, 2025
Globally, public health strategies have focused on tobacco control measures to make smoking less appealing. While tobacco control has a role to play, it is only part of the solution.
By Air 2, LLC June 11, 2025
Moist? Moister? Moistest... Alp's Momentum Accelerates, But Upside Is Limited.
By Air 2, LLC June 5, 2025
Can Smoke-Free Products Power Philip Morris' Next Decade of Growth?
By Air 2, LLC May 30, 2025
Modern oral nicotine steals the spotlight as the Vape category grapples with illicit products and PMTA delays.
By Air 2, LLC May 13, 2025
The nicotine industry is constantly innovating, delivering new products to the market – and that keeps public health researchers busy as they work to understand the implications of each new offering.
More Posts